The combined effects were remarkably more suppressive on tumor growth (Figure 9B) and also concurrently prevented the AD phenotype from establishing itself in early stage tumor formation as defined by the absence of MAP2+ cells irrespective of AD or AI inoculation (Figure 10C). Here, MAP2 is linked to Alzheimer disease.